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Abstract
Infection and chronic inflammation have been recognized as important factors for carcinogenesis. Under inflammatory
conditions, reactive oxygen species (ROS) and reactive nitrogen species (RNS) are generated from inflammatory and
epithelial cells, and result in the formation of oxidative and nitrative DNA lesions, such as 8-oxo-7,8-dihydro-2’-
deoxyguanosine (8-oxodG) and 8-nitroguanine. The DNA damage can cause mutations and has been implicated in
inflammation-mediated carcinogenesis. It has been estimated that various infectious agents are carcinogenic to humans
(IARC group 1), including bacterium Helicobacter pylori (H. pylori), viruses [hepatitis B virus (HBV), hepatitis C virus (HCV),
human papillomavirus (HPV) and Epstein-Barr virus (EBV)] and parasites [Schistosoma haematobium (SH) and Opisthorchis
viverrini (OV)]. H. pylori, HBV/HCV, HPV, EBV, SH and OV are important risk factors for gastric cancer, hepatocellular
carcinoma, nasopharyngeal carcinoma, bladder cancer, and cholangiocarcinoma, respectively. We demonstrated that 8-
nitroguanine was strongly formed via inducible nitric oxide synthase (iNOS) expression at these cancer sites of patients.
Moreover, 8-nitroguanine was formed in Oct3/4-positive stem cells in SH-associated bladder cancer tissues, and in Oct3/4-
and CD133-positive stem cells in OV-associated cholangiocarcinoma tissues. Therefore, it is considered that nitrative and
oxidative DNA damage in stem cells may play a key role in infection-related carcinogenesis via chronic inflammation.
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Background
Infection and chronic inflammation have been recognized
as important risk factors for carcinogenesis and malignan-
cies [1–3]. The International Agency for Research on
Cancer (IARC) has estimated that approximately 18 % of
cancer cases worldwide are attributable to infectious dis-
eases caused by bacteria, viruses, and parasites [4]. Human
cancer caused by infectious agents is shown in Table 1.
The following ten infectious agents have been classified as
group 1 carcinogens (carcinogenic to humans) by IARC:
bacterium Helicobacter pylori (H. pylori), viruses [hepatitis
B virus (HBV), hepatitis C virus (HCV), human papillo-
mavirus (HPV), Epstein-Barr virus (EBV), human T-cell
lymphotropic virus type 1 (HTLV-1) and human im-
munodeficiency virus-1 (HIV-1)] and parasites [Schisto-
soma haematobium (SH), Opisthorchis viverrini (OV)
and Clonorchis sinensis (CS)] [4, 5]. Inflammation can
be induced not only by chronic infection, but also by
many other physical, chemical and immunological fac-
tors [6]. It has been estimated that chronic inflamma-
tion accounts for approximately 25 % of human cancers
[6]. Cancer risk is heavily influenced by environmental
factors such as infections. HPV, HBV/HCV and H.
pylori may be responsible for about 90 % of cervical
cancer cases, 80 % of hepatocellular carcinoma cases
and 65–80 % of gastric cancer cases, respectively [7].
DNA damage in inflammation-related carcinogenesis
Under inflammatory conditions, reactive oxygen species
(ROS) and reactive nitrogen species (RNS) are generated
from inflammatory and epithelial cells. ROS and RNS
are capable of causing damage to various cellular con-
stituents, such as nucleic acids, proteins and lipids. ROS
are generated from multiple sources, including
inflammatory cells, carcinogenic chemicals and their me-
tabolites, and the electron transport chain in mitochon-
dria [2, 3]. ROS can induce the formation of oxidative
DNA lesion products, including 8-oxo-7,8-dihydro-2’-
deoxyguanosine (8-oxodG), which is considered to be
mutagenic [8].
Nitric oxide (NO) is synthesized by NO synthases.
There are three isoforms, neuronal NO synthase (nNOS,
also known as NOS1), inducible NO synthase (iNOS or
NOS2) and endothelial NO synthase (eNOS or NOS3)
[9, 10]. iNOS is activated to drastically generate NO in
inflammatory and epithelial cells under inflammatory
Table 1 Human cancer caused by infectious agents worldwide and possible markers









H. pylori Stomach 490,000 5.4 Patients [31, 76] SALL4, KLF5, LgR5
Viruses
HPV Cervix and other sites 550,000 6.1 Patients [52] CK17
CD44 (HPV16)
Oct3/4 (HPV16)
HBV, HCV Liver 390,000 4.3 Patients with HCV [39]







99,000 1.1 Patients [57] LMP2A
LMP1, Bmi-1
HHV-8 Kaposi sarcoma 54,000 0.6
HTLV-1 Leukemia 9,000 0.1
Parasites




Liver flukes Cholangiocarcinoma 800







Total cancers in 1995 9,000,000 100
Abbreviations: CSC cancer stem cell, Refs. references
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conditions, while eNOS and nNOS are constitutively
expressed and produce relatively small amounts of NO.
iNOS can be also up-regulated by transcription factors
such as NF-kB, HIF-1α, STAT, tumor necrosis factor-α
(TNF-α). NF-kB plays a central role in inflammation
through its ability to induce transcription of proinflam-
matory genes, including iNOS, and functions as a tumor
promoter in inflammation-associated cancer [11].
Figure 1 shows 8-nitroguanine formation under inflam-
matory conditions and resulting mutation. NO reacts with
superoxide (O2
−) to form peroxynitrite (ONOO−), a highly
reactive species causing 8-oxodG and 8-nitroguanine
[12]. The reaction of guanine with ONOO− forms 8-
nitroguanine as the major compound, while adenine
nitration is minor compared to its C8-oxidation [13].
The glycosidic bond between 8-nitroguanine and de-
oxyribose is chemically unstable, and this DNA lesion
can be spontaneously released, resulting in the forma-
tion of an apurinic site [14]. The apurinic site can
form a pair with adenine during DNA synthesis, leading
to G:C to T:A transversions [15]. In addition, translesion
DNA polymerases were discovered and their role in the
mutagenesis has been investigated [16]. Cells deficient in
Rev1 and Rev3, subunits of DNA polymerase ζ, were
hypersensitive to nitrative stress, and translesion DNA
synthesis past apurinic sites mediated by this polymerase
might contribute to extensive point mutations [17]. It has
been reported that adenine is preferentially incorporated
opposite 8-nitroguanine during DNA synthesis catalyzed
by polymerase η and a truncated form of polymerase kin a
cell-free system, suggesting that G:C to T:A transversions
can occur [18].
8-Nitroguanine is considered to be not only a marker
of inflammation, but also a potential mutagenic DNA
lesion involved in carcinogenesis [19]. We have investi-
gated the formation of 8-nitroguanine and 8-oxodG in
various clinical specimens and animal models in relation
to inflammation-related carcinogenesis, as summarized
in Table 1. When specimens or cultured cells were
pretreated with RNase, 8-nitroguanine was more clearly
observed in the nuclei of cells by immunostaining. It
suggests that 8-nitroguanine is formed mainly in
genomic DNA. It is noteworthy that nitrative and oxida-
tive DNA lesions were specifically induced at cancer
sites under chronic infection and various inflammatory
conditions, as reviewed previously [2, 3, 20]. We demon-
strated that 8-nitroguanine was strongly formed via
iNOS expression at related cancer sites of H. pylori,
HBV, HCV, HPV, EBV and SH, OV [2, 3, 21, 22]. The
IARC classification of CS has been recently updated
from 2A to 1, so we have not yet collected enough data
for 8-nitroguanine.
Nitrative and oxidative stresses cause DNA damage,
contributing to the accumulation of mutations in tissues
throughout the carcinogenic process. Particularly, 8-
nitroguanine formation may participate in inflammation-
related carcinogenesis as a common mechanism. There-
fore, 8-nitroguanine could be used as a potential bio-
marker of inflammation-related carcinogenesis.
Cancer stem cell markers in inflammation-related
carcinogenesis
The cancer stem cell concept is widely accepted as im-
portant for overcoming cancer [23]. Several studies have
revealed that cancer stem cells show accumulation of
mutations, genetic instability and epigenetic change sug-
gesting that cancer is also a disease of genes. The most
important question is how to generate cancer stem cells.
Recently, many studies have been reported on the ex-
pressions of stemness cell markers in various kinds of
cancer. Table 1 summarizes possible markers of cancer
stem cells, especially related to each inflammatory causa-
tive agent [20]. We reported that 8-nitroguanine was
strongly formed at all of these cancer sites from animals
and patients with infectious agents. Importantly, we also
detected co-localization of 8-nitroguanine and stemness
marker in infection-related carcinogenesis, as mentioned
in the next section. On the basis of our recent studies, it
is considered that chronic inflammation can increase
mutagenic DNA lesions through ROS/RNS generation
and can promote proliferation via stem cells activation
for tissue regeneration (Fig. 2). This idea is also sup-
ported by other papers about the association of cancer
stem cells with infection and inflammation [24, 25].
Fig. 1 Proposed mechanism of mutation mediated by 8-nitroguanine formation
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H. pylori infection and gastric cancer
The presence of the Gram-negative bacterium, H. pylori
is associated with not only chronic atrophic gastritis and
peptic ulcer but also gastric adenocarcinoma and non-
Hodgkin’s lymphoma [mucosa-associated lymphoid tissue
(MALT) lymphoma] [26]. H. pylori may be responsible for
65–80 % of gastric cancer cases [27]. The mechanisms by
which H. pylori infection causes gastric cancer have been
investigated (Fig. 3). Cytotoxin-associated gene A (CagA)
protein is delivered into gastric epithelial cells, and medi-
ates activation of Src homology 2 domain-containing
phosphatase 2 (SHP2) tyrosine phosphatase by specifically
binding and conformation change, resulting to abnormal
proliferation and promotion of cell motility [28]. CagA
also play a role in disruption of construction of gastric
mucosa by interacting with and inhibiting partitioning-
defective 1 (PAR1)/microtubule affinity-regulating kinase
(MARK) [29]. Peptidoglycan has been described as a pos-
sible factor inducing nucleotide-binding oligomerization
domain protein 1 (Nod1)-mediated NF-kB signaling,
which can induce iNOS expression [30].
We performed a double immunofluorescence labeling
study and demonstrated that the intense immunoreactivities
of 8-nitroguanine and 8-oxodG were observed both in gas-
tric gland epithelial cells and inflammatory cells in patients
with H. pylori infection (Fig. 4, upper panels) [31].
Moreover, these immunoreactivities were decreased
after eradication (Fig. 4, lower panels). It has been re-
ported that the expression of iNOS was significantly
increased in H. pylori-positive gastritis compared to
H. pylori-negative gastritis [32]. These suggest that
nitrative and oxidative DNA damage in gastric epithe-
lial cells and their proliferation by H. pylori infection
may lead to gastric carcinoma.
There are several papers concerning the relation of
cancer stem cells in H. pylori induced carcinogenesis.
H. pylori colonize and manipulate the progenitor and
stem cell components, which alters turnover kinetics
and glandular hyperplasia [33]. H. pylori infection and
inflammation leads to an epithelial-mesenchymal tran-
sition (EMT) and altered tissue regeneration and
differentiation from both local epithelial stem cells
and bone marrow-derived cells (BMDCs) [34]. These
abilities to alter the stem cells may be involved in
generating cancer stem cells, in addition to mutagenic
DNA damage.
Fig. 2 Possible mechanism for generating mutant stem cells by inflammation
Fig. 3 Mechanism of carcinogenesis induced by H. pylori infection
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HBV or HCV infection and liver cancer
HBV or HCV is a major cause of chronic hepatitis, liver
cirrhosis, and hepatocellular carcinoma throughout the
world [35, 36]. HBV / HCV may account for about 80 %
of hepatocellular carcinoma cases [37, 38]. It is generally
accepted that hepatocellular carcinoma arises through a
multistep process of genetic alterations in hepatocytes
during chronic hepatitis C (CHC). However, the mech-
anism of HCV infection-induced hepatitis followed by
hepatocarcinogenesis via DNA damage is still unclear.
We investigated DNA damage in liver biopsy speci-
mens of patients with CHC and the effect of interferon
treatment. Immunoreactivities of 8-nitroguanine and 8-
oxodG were strongly detected in the liver from patients
with CHC in Fig. 5 [39]. 8-Nitroguanine accumulation
was found in not only infiltrating inflammatory cells but
also hepatocytes particularly in the periportal area. The
accumulation of 8-nitroguanine and 8-oxodG increased
with inflammatory grade. iNOS expression was observed
in the cytoplasm of hepatocytes and Kupffer cells in
CHC patients [39]. In the sustained virological re-
sponder group after interferon therapy (+INF in Fig. 5a),
the accumulation of 8-nitroguanine and 8-oxodG in the
liver was markedly decreased [39]. Our results are con-
sistent with the previous reports showing that the ex-
pression of iNOS in hepatocytes has been observed in
patients with chronic hepatitis [40] and hepatocellular
carcinoma [41]. Moreover, we demonstrated the accu-
mulation of 8-nitroguanine and expression of iNOS in
liver tissues of mice infected with HBV (Fig. 5). Taken
together, these findings indicate that 8-nitroguanine is a
useful biomarker to evaluate the severity of HBV/HCV-
induced chronic inflammation leading to hepatocellular
carcinoma.
Fig. 4 8-Nitroguanine and 8-oxodG formation in gastritis patients with H. pylori infection. Double immunofluorescence staining of paraffin
sections shows the localization of 8-nitroguanine (red) and 8-oxodG (green) in the gastric epithelium. Yellow colour in right panels (Merge) shows
co-localization of 8-nitroguanine and 8-oxodG
Fig. 5 Left: 8-Nitroguanine and 8-oxodG accumulation in liver tissues from patients [39]. Right: 8-Nitroguanine accumulation and iNOS expression
in liver tissues from mice (unpublished data)
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It has been reported that hepatic progenitor cells in-
crease in the liver of HCV patients as the disease ad-
vances to cirrhosis, while CD133 (stem/progenitor cell
marker) -positive cancer stem cells correlated with early
recurrence and poor prognosis among HBV related
HCC patients [38]. HBV/HCV modulate hypoxic path-
ways to adapt cells in hypoxic conditions conferring EMT
characteristics [38]. Hypoxia sustains the self-renewal
characteristics of a portion of cancer cells in hypoxic
niches mainly due to the upregulation of Oct4, NANOG,
SOX2, Klf4, and c-myc [38]. It is necessary to study
whether 8-nitroguanine forms in cancer stem cells.
Human papillomavirus and cervical cancer
Cervical cancer is the fourth most common cancer
among women worldwide and approximately 70 % of
the cases occur in developing countries [42]. HPV may
cause about 90 % of cervical cancer cases [43]. Virtually
all cases of cervical cancer are attributable to persistent
infection with HPV [44]. IARC has evaluated several
high-risk types of HPV, including HPV-16, 18, 31, 33,
35, 39, 45, 51, 52, 56, 58 and 59, to be carcinogenic to
humans (group 1) [45, 46]. HPV infection is a necessary
event that precedes the development of cervical intrae-
pithelial neoplasia (CIN), a premalignant lesion, which
partially progresses to cancer [47]. Figure 6 shows a
schematic diagram of HPV-induced carcinogenesis. E6
and E7 participate in HPV-induced carcinogenesis by in-
activating the tumor suppressor gene products, p53 and
Rb, respectively. E6 and E7 expression is necessary but
not sufficient to transform the host cell, as genomic in-
stability is required to acquire the malignant phenotype
in HPV-initiated cells. Recently, Marullo et al. reported
that HPV16 E6 and E7 proteins induced a chronic
oxidative stress, to cause genomic instability and in-
creased susceptibility to DNA damage [48]. In addition,
inflammation-mediated DNA damage may be involved
in cervical carcinogenesis.
Although it is unclear whether HPV infection alone
induces the inflammatory responses, epidemiological
studies have suggested that cervical inflammation in
HPV-infected women is associated with cervical neopla-
sia [47, 49]. Co-infection with HPV and other pathogens
increase the risk of cervical cancer. Among HPV DNA-
positive women, infection with herpes simplex virus-2 is
associated with the risk of invasive cervical carcinoma.
Molecular epidemiological studies have shown that
COX-2 is overexpressed in cervical cancer [50, 51].
These findings suggest that inflammation plays a sub-
stantial role in HPV-mediated carcinogenesis.
To clarify the role of inflammation-mediated DNA
damage in cervical carcinogenesis, we examined 8-
nitroguanine formation in cervical biopsy specimens of
patients obtained from HPV-infected patients. We com-
pared the extent of 8-nitroguanine formation in patients
with different stages of CIN caused by high-risk HPV and
condyloma acuminatum, benign cervical warts caused by
low-risk HPV. 8-Nitroguanine was formed in the nuclei of
atypical epithelial cells of CIN patients but not in condyl-
oma acuminatum patients. Statistical analysis revealed
that the staining intensity of 8-nitroguanine was sig-
nificantly increased in the order of condyloma acumi-
natum < CIN1 < CIN2-3 [52]. Inflammation-mediated
DNA damage, which precedes the genomic abnormal-
ities caused by HPV oncoproteins, may play an im-
portant role in carcinogenesis.
The formation of nitrative DNA lesion during cervical
carcinogenesis has been supported by a recent study.
Fig. 6 Development of HPV-induced cervical cancer
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NO induced DNA damage and increased mutation in
HPV-positive human cervical epithelial cell lines estab-
lished from CIN patients [53]. In addition, NO increased
the expression of E6 and E7 genes, resulting in de-
creased p53 and RB protein levels in these cells [53].
These findings raise the possibility that NO-mediated
DNA damage and viral oncoproteins cooperatively con-
tribute to HPV-induced cervical carcinogenesis (Fig. 7).
López et al. reviewed human papillomavirus infections
and cancer stem cells of tumors from the uterine cervix
[54]. Stem cell associated proteins including human
chorionic gonadotropin, the oncogene TP63 and the
transcription factor SOX2 were upregulated in samples
from women with CIN3 [55]. The stem cell related, cell
surface protein podocalyxin was detectable on cells in
samples from a subset of women with CIN3. SOX2 and
TP63 proteins clearly delineated tumour cells in invasive
squamous cervical cancer [55].
Epstein–Barr virus and nasopharyngeal carcinoma
Lymphomas, gastric cancer and nasopharyngeal carcin-
oma (NPC) are strongly associated with EBV infection,
and account for approximately 1 % of cancer cases
worldwide [4]. NPC has a profoundly skewed geograph-
ical incidence, being common in the arctic (Inuits and
Aleuts), North Africa, and South East Asia [56]. The re-
markably higher incidence of NPC among the Chinese,
especially in South China and South Eastern Asia is
mainly attributed to the non-keratinizing subtype, which
has a virtually 100 % association with EBV [4, 56].
We examined 8-nitroguanine and 8-oxodG formation
in biopsy specimens from patients with nasopharyngitis
and NPC in southern China. 8-Nitroguanine and 8-
oxodG were formed in epithelial cells of EBV-positive
patients with chronic nasopharyngitis, and their inten-
sities were significantly stronger in cancer cells of NPC
patients [57]. The serum level of 8-oxodG in NPC
patients was significantly higher than control patients,
suggesting the involvement of oxidative stress [58]. We
confirmed EBV infection at the nasopharyngeal tissues
by using in situ hybridization for EBV-encoded RNAs
(EBERs). Also, a viral protein latent membrane protein 1
(LMP1) was detected in cancer cells from all EBV-
infected patients. LMP1 induces the expression and nu-
clear accumulation of epidermal growth factor receptor
(EGFR), which in turn interacts with the signal trans-
ducer and activator of transcription-3 (STAT3) in the
nucleus, leading to transcriptional activation of iNOS
[59]. In our study, intensive immunoreactivity of iNOS
was detected in the cytoplasm of cancer cells, and EGFR
and phosphorylated STAT3 were strongly expressed in
cancer cells of NPC patients. Interleukin (IL)-6 was
expressed in macrophages of nasopharyngeal tissues of
EBV-infected patients. EGFR was accumulated in the
nucleus of LMP1-expressing cells, and the addition of
IL-6 induced the expression of phosphorylated STAT3
and iNOS and the formation of inflammation-related
DNA lesions [3, 57]. The proposed mechanism of EBV-
induced carcinogenesis (Fig. 8), that is, EBV infection
may induce nuclear accumulation of EGFR and IL-6-
mediated STAT3 activation, leading to iNOS expression
and formation of 8-nitroguanine and 8-oxodG.
Recently interesting study has been reported [60]. EBV-
encoded LMP1 could induce development of CD44-positive
stem-like cells in NPC. LMP1 activated and triggered phos-
phoinositide 3-kinase/protein kinase B (PI3K/AKT)
pathway, which subsequently stimulated expression of
CD44, development of side population and tumor
sphere formation.
DNA damage and mutant stem cells induced by
Schistosoma haematobium infection
Chronic infection with SH is associated with urinary
bladder cancer, especially in the Middle East and Africa
[61]. Contact with contaminated river water is the major
risk factor for infection. It is believed that the parasite’s
eggs in the host bladder result in irritation, eventual fi-
brosis and chronic cystitis, leading to carcinogenesis. We
Fig. 7 Possible mechanisms of HPV-induced cervical carcinogenesis
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demonstrated for the first time that 8-nitroguanine is
formed in the tumors of bladder cancer patients with
SH infection, by immunohistochemical analysis [21].
The formation of 8-nitroguanine and 8-oxodG was
significantly higher in bladder cancer and cystitis tissues
than in normal tissues. iNOS expression was co-
localized with NF-kB in 8-nitroguanine-positive tumor
cells from bladder cancer patients. NF-kB can be acti-
vated by TNF-α, a major mediator of inflammation,
stimulated by SH egg antigen. These suggest that both
8-nitroguanine and 8-oxodG are formed by iNOS-
mediated NO overproduction via NF-kB activation,
under SH-caused chronic inflammation.
A stemness marker, Oct3/4, is necessary for maintain-
ing the self-renewing, cancer stem-like, and chemora-
dioresistant properties of tumorigenic stem-like cell
populations [62, 63], and is thus considered to play roles
in the carcinogenesis process. Another stemness marker,
CD44, has been identified as a cell surface marker asso-
ciated with cancer stem cells in tumors [64, 65], includ-
ing urinary bladder cancer. Expression of CD44v6, a
splicing variant of CD44, is correlated with proliferation
of poorly differentiated urothelial cells and the charac-
teristic phenotype of tumor-initiating bladder cancer
stem cells [66, 67]. Our previous reports have showed
that SH-induced urinary bladder cancer correlates with
the expression of Oct3/4 [21], while urinary bladder can-
cer without the infection correlates with the expression
of CD44v6 [22]. It is noteworthy that different risk
factors induce different levels of expression of stemness
markers in urinary bladder carcinoma. Moreover, 8-
nitroguanine was formed in Oct3/4-positive stem cells
in SH-associated cystitis and cancer tissues as shown in
Fig. 9 [21]. Inflammation by SH infection may increase
the number of mutant stem cells, in which iNOS-
dependent DNA damage occurs via NF-kB activation,
leading to tumor development.
DNA damage and mutant stem cells induced by OV
infection
Chronic infection with the liver flukeOV is associated with
cholangiocarcinomas (CCA) [5]. Repeated intake of raw
fish containing the infective stage of OV is a cause of the
parasite-induced CCA. Re-infection with OV is a major
risk factor of CCA in northeast Thailand. We assume that
OV-associated CCA is one of a model of inflammation-
mediated carcinogenesis. We demonstrated 8-nitroguanine
and 8-oxodG formation in the bile duct of hamsters fed
with metacercariae of OV [68–70]. These DNA le-
sions were observed in inflammatory cells and epithe-
lium of bile ducts, and their formation increased in a
manner dependent on infection times. The anthel-
minthic drug praziquantel dramatically diminished the
DNA lesions and iNOS expression in OV-infected
hamsters. Thus, repeated OV-infection can induce the
iNOS-dependent nitrative and oxidative damage to
nucleic acids in bile ducts via NF- k B expression,
which may participate in CCA.
In our study with patients, the formation of 8-oxodG
and 8-nitroguanine occurred to a much greater extent in
cancerous tissues than in non-cancerous tissues in CCA
patients, indicating that these DNA lesions contribute to
Fig. 8 Proposed mechanism of EBV-induced carcinogenesis
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tumor initiation [71]. Urinary 8-oxodG levels were sig-
nificantly higher in CCA patients than in OV–infected
patients, and higher in OV–infected subjects than in
healthy subjects. The urinary 8-oxodG levels in OV–in-
fected patients significantly decreased two months after
praziquantel treatment [72].
Our study with proteomics approach showed that oxi-
dation of serotransferrin, alpha-1-antitrypsin (A1AT) and
heat shock protein 70-kDa protein 1 (HSP70.1) were sig-
nificantly associated with poor prognoses [73]. HSP70.1
acts as a molecular chaperone to protect various cells
from oxidative stress. A1AT, a glycoprotein, is a member
of the serpins (serine protease inhibitors), inhibitors of a
wide variety of proteases in relation to tumor invasion.
Serotransferrin (transferrin) is an iron (Fe3+)-binding and
-transporting protein. Interestingly, we observed that sero-
transferrin was highly expressed and co-localized with
iron in the tumor, suggesting iron accumulation and its
release from oxidatively-damaged serotransferrin. We
have proposed that oxidative damage of serotransferrin,
HSP70.1 and A1AT may induce oxidative stress by iron-
accumulation and dysfunction of anti-oxidative and anti-
invasive properties, leading to increased oxidative DNA
damage and progression of CCA.
Recently, we observed high expression and co-
localization of hepatocyte marker and cholangiocyte
marker in OV-associated CCA patients, suggesting the
involvement of stem cells in CCA development [74].
Stem/progenitor cell markers (CD133 and OV6) were
positively stained in CCA cases (Fig. 10). Quantitative
analysis of 8-oxodG revealed significantly increased
levels in CD133- and/or Oct3/4-positive tumor tissues
compared to negative tumor tissues, suggest that CD133
and Oct3/4 in CCA are associated with increased forma-
tion of DNA lesions [74]. Moreover, CD133- and Oct3/
4-positive CCA patients had significant associations with
poor prognoses. These findings suggest that CD133 and
Oct3/4 in CCA are highly associated with formation of
DNA lesions, which may be involved in mutant stem
Fig. 9 Formation of 8-nitroguanine and expression of Oct3/4 in bladder tissues. The formation of 8-nitroguanine (red) and the expression of Oct3/4
(green) were assessed by double immunofluorescence staining [21]. In the merged image, co-localization of 8-nitroguanine and Oct3/4 is indicated in
yellow. Biopsy and surgical specimens were obtained from normal subjects and patients with SH-induced cystitis and bladder cancer. Normal tissues
and urinary bladder cancer tissues without SH-infection were obtained from a commercial urinary bladder tissue array (Biomax.us, USA)
Fig. 10 Colocalization of stem cell markers and DNA damage. Double-
immunofluorescence staining of stem/progenitor cell markers (CD133 and
OV6) and DNA lesions (8-oxodG and 8-nitroguanine) in cholangiocarcinoma
tissues. White arrows indicate co-localization of DNA damage
marker and stemness marker in cancer cells. Original magnification
is × 400; Scale bar = 25 μm
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cells, leading to cancer stem cells. Inflammation by OV
infection may increase the number of mutant stem cell
under oxidative and nitrative stresses, and the mutant
stem cell proliferation may promote to be cancer stem
cells of CCA.
Conclusions
Nitrative and oxidative DNA lesions with mutagenic prop-
erties are formed in various types of inflammation-related
cancer tissues. We have proposed a mechanism for the
generation of cancer stem cells by inflammation in Fig. 2.
Chronic inflammation by infectious agents, inflammatory
diseases, and other factors causes various types of damage
to nucleic acids, proteins, tissue and so on, via ROS/RNS
generation. Tissue injury under chronic inflammation may
activate progenitor/stem cells for regeneration. In these
cells, ROS/RNS from inflammation can cause multiple
mutations, which may generate mutant stem cells and
cancer stem cells, leading to carcinogenesis. Indeed, 8-
nitroguanine was formed in stemness marker-positive
cells in parasite-associated cancer tissues. The mechanism
for generation of cancer stem cells will be explained by
our ongoing studies on the formation of 8-nitroguanine in
stem-like cells of target tissues associated with other
inflammation-related cancers.
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